Premium Nahrungsergänzungsmittel | artgerecht

undefined

Regular tips about health Regular tips about health

Things worth knowing about "Lupus erythematosus"

Lupus erythematosus is a chronic autoimmune disease in which the immune system attacks the body's own tissues, affecting the skin, joints, kidneys, and other organs.

What is Lupus Erythematosus?

Lupus erythematosus (LE) is a chronic, inflammatory autoimmune disease in which the immune system mistakenly attacks healthy body tissues. The most common and severe form is systemic lupus erythematosus (SLE), which can affect multiple organ systems including the skin, joints, kidneys, heart, lungs, and nervous system. The disease typically follows a relapsing-remitting course, with periods of flare-ups alternating with quieter phases.

Forms of Lupus Erythematosus

Systemic Lupus Erythematosus (SLE): The most common and severe form, capable of affecting multiple organs simultaneously.
Cutaneous Lupus Erythematosus (CLE): Primarily affects the skin, with subtypes including discoid lupus erythematosus (DLE).
Drug-induced Lupus: Triggered by certain medications and typically resolves after discontinuation of the causative drug.
Neonatal Lupus: A rare form affecting newborns, caused by maternal autoantibodies crossing the placenta.

Causes and Risk Factors

The exact cause of lupus erythematosus is not fully understood. It is considered to result from a combination of factors:

Genetic predisposition: A family history of lupus increases susceptibility; several specific genes are associated with elevated risk.
Hormonal influences: Women of childbearing age are significantly more affected, suggesting a role for estrogen in disease development.
Environmental triggers: UV radiation, infections, physical or emotional stress, and certain medications can trigger flares.
Immune dysregulation: Defective regulation of the immune system leads to the production of autoantibodies against the body's own tissues.

Symptoms

Symptoms of lupus erythematosus are highly variable depending on which organs are involved:

Skin changes: The characteristic butterfly rash (a reddish rash across the nose and cheeks) is a hallmark sign of SLE.
Joint and muscle pain: Arthritis and myalgia are common complaints.
General symptoms: Fatigue, fever, and unexplained weight loss.
Kidney involvement (lupus nephritis): Inflammation of the kidneys, which can progress to kidney failure if untreated.
Heart and lung involvement: Pericarditis (inflammation of the sac around the heart) and pleuritis (inflammation of the lung lining).
Neurological symptoms: Headaches, seizures, and cognitive difficulties.
Blood abnormalities: Anemia, reduced white blood cell count, or low platelet count.

Diagnosis

Diagnosing lupus erythematosus can be challenging because it mimics many other conditions and affects multiple organ systems. Diagnosis is based on clinical features and laboratory findings:

Blood tests: Detection of antinuclear antibodies (ANA), anti-double-stranded DNA (anti-dsDNA) antibodies, and other autoantibodies.
Urinalysis: To detect kidney involvement through proteinuria or hematuria.
Complete blood count: To identify anemia, leukopenia, or thrombocytopenia.
Imaging: Ultrasound, X-ray, or MRI to evaluate organ involvement.
Classification criteria: Diagnosis is guided by the EULAR/ACR 2019 classification criteria for SLE.

Treatment

There is currently no cure for lupus erythematosus. Treatment focuses on controlling disease flares, preventing organ damage, and improving quality of life:

Pharmacological Treatment

Antimalarials (Hydroxychloroquine): Considered the cornerstone of lupus therapy for almost all patients; reduces flare frequency and protects against organ damage.
Corticosteroids (e.g., prednisolone): Used for rapid anti-inflammatory effect during acute flares.
Immunosuppressants (e.g., azathioprine, mycophenolate mofetil, cyclophosphamide): For long-term management of severe or organ-threatening disease.
Biologics (e.g., belimumab, anifrolumab): Targeted therapies for patients with inadequate response to standard treatment.

Non-pharmacological Measures

Consistent UV protection (high-SPF sunscreen, protective clothing)
Regular medical follow-up to monitor for organ damage
Stress management and a healthy lifestyle

Prognosis

The prognosis for lupus erythematosus has improved significantly with modern treatment options. Many patients lead largely normal lives with appropriate management. However, severe organ involvement -- particularly kidney disease -- can affect life expectancy. Regular monitoring and consistent adherence to therapy are essential for the best possible outcomes.

References

Fanouriakis A, et al. - 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases, 2019.
Aringer M, et al. - 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis and Rheumatology, 2019.
Tsokos GC - Systemic Lupus Erythematosus. New England Journal of Medicine, 365(22): 2110-2121, 2011.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.